Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 11/2011

01-11-2011 | Review Article

Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors

Authors: Armen Yuri Gasparyan, Lilit Ayvazyan, Heather Blackmore, George D. Kitas

Published in: Rheumatology International | Issue 11/2011

Login to get access

Abstract

Review articles comprehensively covering a specific topic are crucial for successful research and academic projects. Most editors consider review articles for special and regular issues of journals. Writing a review requires deep knowledge and understanding of a field. The aim of this review is to analyze the main steps in writing a narrative biomedical review and to consider points that may increase the chances of success. We performed a comprehensive search through MEDLINE, EMBASE, Scopus, and Web of Science using the following keywords: review of the literature, narrative review, title, abstract, authorship, ethics, peer review, research methods, medical writing, scientific writing, and writing standards. Opinions expressed in the review are also based on personal experience as authors, peer reviewers, and editors.
Literature
1.
Gasparyan AY, Banach M (2009) A medium of science communication in our times. Arch Med Sci 5:1–2
2.
3.
Gasparyan AY (2010) Thoughts on impact factors and editing of medical journals. Inflamm Allergy Drug Targets 9:2–5PubMed
4.
Werbin N (2005) [Review articles–to write, to read or to throw away?]. Harefauh 144:558–560, 598 (Hebrew)
5.
Habibi E, Mirhosseini Z, Majidi M (2010) Medical publications (2002–2009) of islamic countries; a Medline-based study compared to non-islamic countries. Iran J Med Sci 35:226–235
6.
Smith R (2006) The trouble with medical journals. J R Soc Med 99:115–119
7.
8.
Jacobs A, Wager E (2005) European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin 21:317–322PubMedCrossRef
9.
10.
Moore A (2010) What’s in a title? A two-step approach to optimisation for man and machine: writing good titles is a crucial part of optimising articles’ chances of being peer reviewed, and later found in the literature via Google: here are some tips. Bioessays 32:183–184PubMedCrossRef
11.
Luo YH (2010) How to write an effective English title for an andrological paper? Zhonghua Nan Ke Xue 16:99–105
12.
Christensen NB, Kume H, Autorino R (2009) How to write titles and abstracts for readers. Int J Urol 16:2–3PubMedCrossRef
13.
14.
Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ, Kitas GD (2008) Hypertension in rheumatoid arthritis. Rheumatology (Oxford) 47:1286–1298CrossRef
15.
16.
17.
Keiserman B, da Silva LF, Keiserman MW, von Mühlen CA, Staub HL (2010) Lupoid sclerosis. Rheumatol Int 30:431–434PubMedCrossRef
18.
Hasani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M (2010) The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. Curr Pharm Des 16:2935–2947PubMed
19.
Ligthart SA, van Charante EP, Van Gool WA, Richard E (2010) Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review. Vasc Health Risk Manag 6:775–785PubMedCrossRef
20.
Yao Q, Altman RD, Brahn E (2009) Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature. Semin Arthritis Rheum 38:458–466PubMedCrossRef
21.
Rashid-Farokhi F, Cheraghvandi A, Masjedi MR (2009) Pheochromocytoma crisis due to glucocorticoid administration: a case report and review of the literature. Arch Iran Med 12:190–194PubMed
22.
Trapani S, Mariotti P, Resti M, Nappini L, de Martino M, Falcini F (2010) Severe hemorrhagic bullous lesions in Henoch Schonlein purpura: three pediatric cases and review of the literature. Rheumatol Int 30:1355–1359PubMedCrossRef
23.
Kornerup KN, Page CP (2007) The role of platelets in the pathophysiology of asthma. Platelets 18:319–328PubMedCrossRef
24.
Eleftheriadis T, Lawson BR (2009) Toll-like receptors and kidney diseases. Inflamm Allergy Drug Targets 8:191–201PubMed
25.
Salari Sharif P, Abdollahi M (2010) The role of platelets in bone remodeling. Inflamm Allergy Drug Targets 9:393–399
26.
Woollard KJ, Chin-Dusting J (2007) Therapeutic targeting of p-selectin in atherosclerosis. Inflamm Allergy Drug Targets 6:69–74PubMedCrossRef
27.
Cocco G, Chu DC, Pandolfi S (2010) Colchicine in clinical medicine. A guide for internists. Eur J Intern Med 21:503–508PubMedCrossRef
28.
Leaf A, Kang JX, Xiao YF (2008) Fish oil fatty acids as cardiovascular drugs. Curr Vasc Pharmacol 6:1–12PubMedCrossRef
29.
Hosseini-Tabatabaei A, Abdollahi M (2008) Potassium channel openers and improvement of toxic stress: do they have role in the management of inflammatory bowel disease? Inflamm Allergy Drug Targets 7:129–135PubMedCrossRef
30.
31.
32.
Kitas GD, Erb N (2003) Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) 42:607–613CrossRef
33.
Gasparyan AY, Watson T, Lip GY (2008) The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol 51:1829–1843PubMedCrossRef
34.
Distler JH, Beyer C, Schett G, Lüscher TF, Gay S, Distler O (2009) Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases. Arthritis Rheum 60:3168–3179PubMedCrossRef
35.
Ben-Chetrit E, Touitou I (2009) Familial Mediterranean fever in the world. Arthritis Rheum 61:1447–1453PubMedCrossRef
36.
Hartley J (2004) Current findings from research on structured abstracts. J Med Libr Assoc 92:368–371PubMed
37.
Salari Sharif P, Abdollahi M, Larijani B (2010) Current, new and future treatments of osteoporosis. Rheumatol Int 31:289–300
38.
Vila PM, Zafar MU, Badimon JJ (2009) Platelet reactivity and nonresponse to dual antiplatelet therapy: a review. Platelets 20:531–538PubMedCrossRef
39.
Cleary M, Hunt GE, Horsfall J (2009) Conducting efficient literature searches. J Psychosoc Nurs Ment Health Serv 47:34–41
40.
La Regina M, Gasparyan AY, Orlandini F, Prisco D (2010) Behçet’s disease as a model of venous thrombosis. Open Cardiovasc Med J 4:71–77PubMed
41.
Dotsenko O (2010) Stem/Progenitor cells, atherosclerosis and cardiovascular regeneration. Open Cardiovasc Med J 4:97–104PubMed
42.
Mulrow CD (1987) The medical review article: state of the science. Ann Intern Med 106:485–488PubMed
43.
McAlister FA, Clark HD, van Walraven C, Straus SE, Lawson FM, Moher D, Mulrow CD (1999) The medical review article revisited: has the science improved? Ann Intern Med 131:947–951PubMed
44.
Falagas ME, Pitsouni EI, Malietzis GA, Pappas G (2008) Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J 22:338–42
45.
46.
47.
Merat S, Khatibzadeh S, Mesgarpour B, Malekzadeh R (2009) A survey of the current status of web-based databases indexing Iranian journals. Arch Iran Med 12:271–278PubMed
48.
Satyanarayana K, Sharma A (2010) Biomedical journals in India: some critical concerns. Indian J Med Res 132:119–122PubMed
49.
Chand V, Rosenfeldt FL, Pepe S (2008) The publication rate and impact of abstracts presented at the Cardiac Society of Australia and New Zealand (1999–2005). Heart Lung Circ 17:375–379PubMedCrossRef
50.
Van Royen P, Sandholzer H, Griffiths F, Lionis C, Rethans JJ, Galí F, Eilat-Tsanani S, Hummers-Pradier E (2010) Are presentations of abstracts at EGPRN meetings followed by publication? Eur J Gen Pract 16:100–105PubMedCrossRef
51.
Song J, Li M, Hwang DH, Ricciotti RW, Chang A (2010) The outcome of abstracts presented at the United States and Canadian Academy of Pathology annual meetings. Mod Pathol 23:682–685PubMedCrossRef
52.
Davidoff F, DeAngelis CD, Drazen JM, Hoey J, Højgaard L, Horton R, Kotzin S, Nicholls MG, Nylenna M, Overbeke AJ, Sox HC, Van Der Weyden MB, Wilkes MS (2001) Sponsorship, authorship, and accountability. Lancet 358:854–856PubMedCrossRef
53.
Drazen JM, de Leeuw PW, Laine C, Mulrow C, DeAngelis CD, Frizelle FA, Godlee F, Haug C, Hébert PC, James A, Kotzin S, Marusic A, Reyes H, Rosenberg J, Sahni P, Van der Weyden MB, Zhaori G (2010) Toward more uniform conflict disclosures—the updated ICMJE conflict of interest reporting form. N Engl J Med 363:188–189PubMedCrossRef
54.
Hutchison BG (1993) Critical appraisal of review articles. Can Fam Physician 39:1097–1102PubMed
55.
56.
57.
Hochberg ME, Chase JM, Gotelli NJ, Hastings A, Naeem S (2009) The tragedy of the reviewer commons. Ecol Lett 12:2–4PubMedCrossRef
58.
Metadata
Title
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
Authors
Armen Yuri Gasparyan
Lilit Ayvazyan
Heather Blackmore
George D. Kitas
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1999-3

Other articles of this Issue 11/2011

Rheumatology International 11/2011 Go to the issue

Original Article

Factors associated with temporary work disability in patients with fibromyalgia

Original Article

HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients

Case Report

Rare localizations of bone sarcoidosis: two case reports and review of the literature

Original Article

Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life

Original Article

Antibodies against cyclic citrullinated peptide don’t decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis

Original Article

Sinomenine reduces invasion and migration ability in fibroblast-like synoviocytes cells co-cultured with activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, CD147
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits